EXCLUSIVE: Weight-Loss Duopoly Breaks As Eli Lilly, Novo Plummet; 'Market Won't Be Dominated By Just 2 Players'
EXCLUSIVE: GLP-1 Weight-Loss Drugs Could Become A Trillion-Dollar Market, Predicts Tema ETFs CEO
This Weight-loss ETF Has Performed Well in Its First Five Months. How Does It Compare With Cheaper Alternatives?
If you're afraid the “Nolly” stock price will rise, consider this ETF that tracks “diet drug bulls”
Tema Pharmaceuticals and Investments (US stock code: HRTS), an ETF that tracks many pharmaceutical companies focused on the diet drug circuit, can be described as a very good choice. Industry ETF portfolios are diversified, and the volatility is often far less than individual stocks.
Express News | From Healthcare Summit: Tema Investment Partner And Head Of Life Sciences David Song Says Healthcare Sector Is Trading At Reasonable Valuations, Says A Long Term Investor Can Participate In This Area Of Medicine Through HRTS ETF
'Continued Innovation' Is Key When Investing in Weight Loss Trend